
<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/joey/Project/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.4.2-SNAPSHOT" ident="GROBID" when="2017-08-10T23:38+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Vasohibins: new transglutaminase-like cysteine proteases possessing a non-canonical Cys-His-Ser catalytic triad</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName>
								<forename type="first">Luis</forename>
								<surname>Sanchez-Pulido</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiology, Anatomy and Genetics</orgName>
								<orgName type="institution" key="instit1">MRC Functional Genomics Unit</orgName>
								<orgName type="institution" key="instit2">University of Oxford</orgName>
								<address>
									<postCode>OX1 3QX</postCode>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Chris</forename>
								<forename type="middle">P</forename>
								<surname>Ponting</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiology, Anatomy and Genetics</orgName>
								<orgName type="institution" key="instit1">MRC Functional Genomics Unit</orgName>
								<orgName type="institution" key="instit2">University of Oxford</orgName>
								<address>
									<postCode>OX1 3QX</postCode>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Vasohibins: new transglutaminase-like cysteine proteases possessing a non-canonical Cys-His-Ser catalytic triad</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/bioinformatics/btv761</idno>
					<note type="submission">Received on 22 October 2015; revised on 15 December 2015; accepted on 22 December 2015</note>
					<note>Sequence analysis *To whom correspondence should be addressed. Associate Editor: John Hancock Supplementary information: Supplementary data are available at Bioinformatics online.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
				<p>Vasohibin-1 and Vasohibin-2 regulate angiogenesis, tumour growth and metastasis. Their molecular functions, however, were previously unknown, in large part owing to their perceived lack of homology to proteins of known structure and function. To identify their functional amino acids and domains, their molecular activity and their evolutionary history, we undertook an in-depth analysis of Vasohibin sequences. We find that Vasohibin proteins are previously un-detected members of the transglutaminase-like cysteine protease superfamily, and all possess a non-canonical Cys-His-Ser catalytic triad. We further propose a calcium-dependent activation mechanism for Vasohibin proteins. These findings can now be used to design constructs for protein structure determination and to develop enzyme inhibitors as angiogenic regulators to treat me-tastasis and tumour growth.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">Introduction</head><p>Tight regulation of angiogenesis contributes to normal physiology, growth and development, but when misregulated leads to, or dramatically affects, pathological conditions, such as ischaemia, wound healing and cancer (<ref type="bibr" target="#b10">Ferrara and Kerbel, 2005</ref>). Angiogenesis is a fundamental step in transitioning tumours from benignancy to malignancy. The use of angiogenesis inhibitors in treating cancer has thus received considerable attention over the last four decades (<ref type="bibr" target="#b2">Bergers and Benjamin, 2003</ref>). Vasohibin-1 (VASH1) was initially identified as a vascular endothelial growth factor inducible gene that regulates endothelial cell migration (<ref type="bibr" target="#b57">Watanabe et al., 2004;</ref><ref type="bibr" target="#b39">Sato, 2013;</ref><ref type="bibr" target="#b40">Sato, 2015</ref>). Despite lacking a classical secretion signal, human VASH1 protein is released extracellularly, assisted by a small vasohibin-binding protein which is the only known VASH1-interacting protein (<ref type="bibr" target="#b46">Suzuki et al., 2010</ref>). Over-expression of a paralogue, Vasohibin-2 (VASH2), is associated with diverse tumours, with major roles to angiogenesis, malignant transformation, and metastasis (<ref type="bibr" target="#b24">Kim et al., 2015;</ref><ref type="bibr" target="#b26">Kitahara et al., 2014;</ref><ref type="bibr" target="#b27">Koyanagi et al., 2013;</ref><ref type="bibr" target="#b42">Shibuya et al., 2006;</ref><ref type="bibr" target="#b47">Takahashi et al., 2012;</ref><ref type="bibr" target="#b48">Tu et al., 2014;</ref><ref type="bibr" target="#b60">Xue et al., 2013</ref>). Knockout mouse studies have revealed the contrasting roles of the two paralogues (<ref type="bibr" target="#b17">Ito et al., 2013</ref>). VASH1 is expressed in endothelial cells in zones within which angiogenesis is arrested, whilst VASH2 is expressed in infiltrating mononuclear cells at the sprouting front in which angiogenesis is enhanced (<ref type="bibr" target="#b25">Kimura et al., 2009</ref>). The molecular activity of neither paralogue is known, in large part due to a perceived lack of homology to proteins of known structure and function.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Results and discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Computational protein sequence analysis</head><p>We initiated our analyses by performing a JackHMMER iterative search (<ref type="bibr" target="#b11">Finn et al., 2015</ref>) starting from the human VASH1 protein sequence, against the UniRef50 database (<ref type="bibr" target="#b58">Wu et al., 2006</ref>). With the</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>1441</head><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.of fungi, the vasohibin family is widely distributed in eukaryotes: in animals it is represented from humans to placozoans (Trichoplax adhaerens), but is absent from nematodes (Caenorhabditis elegans) and hexapods (Drosophila melanogaster), and in plants homologues are present from green algae to Bryophytes (Physcomitrella patens) but are not in vascular plants. We identified an evolutionarily conserved central region in the vasohibin family, thereby reproducing this unusual phyletic distribution reported in Pfam (Family: vasohibin/PF14822) (<ref type="bibr" target="#b36">Punta et al., 2012</ref>). Vasohibin homologous sequences were identified in standard databases (UniProt, GenBank and Joint Genome Institute data) and in manually assembled ESTs and FGENESHþ-predicted gene models (<ref type="bibr" target="#b44">Solovyev et al., 2006</ref>). Next, we took advantage of HMMer3 and HMMer2 (<ref type="bibr" target="#b9">Eddy, 1996;</ref><ref type="bibr" target="#b11">Finn et al., 2015</ref>) to search UniRef50 for more divergent vasohibin homologues using a hidden Markov model (HMM) generated from the central conserved region (corresponding to human VASH1, UniProt: VASH1_HUMAN, amino acids 125–247). With this profile, HMMer3 identified significant (E-value ¼ 0.011) sequence similarities between the vasohibin HMM and a cryptophyte algae protein from Guillardia theta (UniProt: L1IQR7_GUITH, amino acids 120–227). This G. theta protein is a member of an experimentally uncharacterised family (henceforth, the 'vasohibin-like' family) drawn from phylogenetically heterogeneous organisms. These include Acidobacteria (Solibacter usitatus and Acidobacteriaceae bacterium), Proteobacteria (Bdellovibrio exovorus and Reyranella massiliensis), and eukaryotes (G. theta, Chaetosphaeridium globosum, Chlorokybus atmophyticus and the dinoflagellate Karlodinium veneficum;<ref type="figure">Fig. 1</ref>and Supplementary<ref type="figure">Figure S1</ref>). Profile-versus-sequence (HMMer2 and HMMer3) (<ref type="bibr" target="#b9">Eddy, 1996;</ref><ref type="bibr" target="#b11">Finn et al., 2015</ref>) and profile-versus-profile (HHpred) (<ref type="bibr">Söding et al., 2005</ref>) similarity searches using an HMM representing the central conserved portion of the vasohibin-like family produced concordant results, identifying robust statistical significance (HMMer2 E-value ¼ 0.03 and HMMer3 E-value ¼ 1.2 Â 10 À5 ) for the sequence similarity between vasohibin and vasohibin-like families (Supplementary<ref type="figure">Figure S2</ref>). Unexpectedly, HHpred searches against the PDB70 profile database (<ref type="bibr">Sö ding et al., 2005</ref>), again using the conserved central region of the vasohibin-like family, matched the transglutaminase-like cysteine protease domain of Cytophaga hutchinsonii protein (PDB-ID: 3ISR) with a highly significant E-value of 6.5 Â 10 À4 (<ref type="figure">Fig. 1</ref>and Supplementary<ref type="figure">Figure S2</ref>). Moreover, in support of this first match, the next most statistically significant matches were to five further members of the transglutaminase-like cysteine protease superfamily [PDB-IDs: 3KD4, 4FGQ (LapG), 2F4M, 2BSZ (NAT1) and 4DMO (NAT3)]. Many members of this superfamily are functionally and structurally characterized enzymes classified in different protein databases, such as: Pfam (Clan Peptidase_CA CL0125, containing 60 families), SCOP (Fold: Cysteine proteinases, subdivided in 22 families) and MEROPS database of peptidases (clan CA, carefully subdivided in 36 families) (<ref type="bibr" target="#b0">Andreeva et al., 2004;</ref><ref type="bibr" target="#b36">Punta et al., 2012;</ref><ref type="bibr" target="#b37">Rawlings et al., 2014</ref>). Additionally, secondary structure predictions of the vasohibin and vasohibin-like families corroborated this proposed homology because they yielded high similarity with known transglutaminaselike cysteine protease superfamily structures (<ref type="figure">Fig. 1</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bioinformatics</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Active site conservation</head><p>, a non-canonical catalytic triad relationship between reactive oxygen or nitrogen species (ROS and RNS) and angiogenesis (<ref type="bibr" target="#b16">Huang and Zheng, 2006;</ref><ref type="bibr" target="#b51">Ushio-Fukai, 2007;</ref><ref type="bibr" target="#b52">Ushio-Fukai and Urao, 2009</ref>). ROS and RNS are known to inactivate different members of the transglutaminase-like cysteine protease superfamily, such as papain (<ref type="bibr" target="#b59">Xian et al., 2000</ref>), arylamine N-acetyltransferase (NAT1) (<ref type="bibr" target="#b8">Dupret et al., 2005</ref>) and transglutaminases (<ref type="bibr" target="#b3">Bernassola et al., 1999;</ref><ref type="bibr" target="#b33">Nurminskaya and Belkin, 2012</ref>). We thus suggest that the putative catalytic cysteine residues in VASH1 and VASH2 could be substrates of ROS and RNS activity. Owing to the enzymatic diversity of its transglutaminase-like homologues, our computational analysis is unable to predict the catalytic reaction or substrate of vasohibins. Nevertheless, the discovery of vasohibins as enzyme homologues should now motivate the determination of their protein structures and the development of active site inhibitors that differentiate VASH1 from VASH2. Such inhibitors would be anticipated to modify angiogenesis and thus to be useful for inhibiting metastasis and tumour growth. We note that different inhibitors have already been described for several members<ref type="figure">Fig. 1</ref>. Multiple sequence alignment of representative vasohibin and related families. Multiple sequence alignments for each family were generated with the program T-Coffee (<ref type="bibr" target="#b32">Notredame et al., 2000</ref>) using default parameters and slightly refined manually. The final superfamily alignment was generated using a combination of profile-to-profile comparisons (<ref type="bibr">Sö ding et al., 2005</ref>) and sequence alignments derived from structural super-positions for those families whose tertiary structure is known (PDB IDs: 3isr, 2bsz, 4dmo and 4fgq) (<ref type="bibr" target="#b13">Holm and Sander, 1995</ref>). Active site residues are labelled and coloured according to reference protein sequences: VASH1, NAT3 (human arylamine N-acetyltransferase 3), and calcium-dependent periplasmic cysteine protease LapG in red, pink and violet, respectively. A putative calcium-binding residue (human VASH1 E171) is labelled. Families are indicated by coloured bars to the left of the alignment: Vasohibin, Vasohibin-like and transglutaminase-like cysteine protease are indicated in red, yellow and purple, respectively. The limits of the protein sequences included in the alignment are indicated by flanking residue positions. Secondary structure predictions (<ref type="bibr" target="#b19">Jones, 1999</ref>) were performed independently for the vasohibin and vasohibin-like families (show in ss_predVash and ss_predBac lanes); these are consistent with X-ray determined secondary structures of the putative cysteine protease from C. hutchinsonii (PDB: 3isr) (<ref type="bibr">Stein et al., Midwest</ref>Center for Structural Genomics, unpublished), NAT1 (arylamine N-acetyltransferase-1) from Mesorhizobium loti (PDB: 2bsz) (<ref type="bibr" target="#b14">Holton et al., 2005</ref>), NAT3 (arylamine N-acetyltransferase-3) from Bacillus cereus (PDB: 4dmo) (<ref type="bibr" target="#b28">Kubiak et al., 2013</ref>) and the calcium-dependent periplasmic cysteine protease LapG from Legionella pneumophila (PDB: 4fgq) (<ref type="bibr" target="#b7">Chatterjee et al., 2012</ref>). Alpha-helices and beta-strands are indicated by cylinders and arrows, respectively. The alignment was presented with the program Belvu using a colouring scheme indicating the average BLOSUM62 scores (which are correlated with amino acid conservation) of each alignment column: red (&gt;3), violet (between 3 and 1.5) and light yellow (between 1.5 and 0.5) (<ref type="bibr" target="#b45">Sonnhammer and Hollich, 2005</ref>). Sequences are named according to their UniProt identification or common name (details provided in Supplementary<ref type="figure">Figure  S1</ref>). Below the alignment are shown a homology-model of human VASH1 and known structures of representative members of the transglutaminase-like cysteine protease superfamily. Catalytic triads are labelled and side chains shown using sticks. The human VASH1 structural model was created using Modeller (<ref type="bibr" target="#b38">Sali and Blundell, 1993</ref>). VASH1 model and structures are presented using Pymol (http://www.pymol.org)</p><p>Vasohibins: new transglutaminase-like cysteine proteasesof the transglutaminase-like cysteine protease superfamily (<ref type="bibr" target="#b1">Badarau et al., 2013;</ref><ref type="bibr" target="#b6">Chakka et al., 2015;</ref><ref type="bibr" target="#b22">Keillor et al., 2015;</ref><ref type="bibr" target="#b23">Kerr et al., 2009;</ref><ref type="bibr" target="#b29">Kukongviriyapan et al., 2006;</ref><ref type="bibr" target="#b34">Pandey and Dixit, 2012;</ref><ref type="bibr" target="#b43">Sim et al., 2014;</ref><ref type="bibr" target="#b49">Turk et al., 1997;</ref><ref type="bibr" target="#b61">Zhou et al., 2013</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">Conclusion</head><p>Given the strong statistical significance of sequence and profile comparisons, and the concordance of secondary structure predictions and conserved active site residues, we have shown that vasohibin proteins are new members of the transglutaminase-like cysteine protease superfamily, and possess a non-canonical Cys-His-Ser/Thr catalytic triad. This insight should immediately help guide experiments to clarify the molecular mechanisms by which VASH1 and VASH2 control angiogenesis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p>This work was supported by Medical Research Council UK. Conflict of Interest: none declared.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="false"><figDesc>V C The Author 2016. Published by Oxford University Press.</figDesc><table></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" validated="false"><figDesc>, 32(10), 2016, 1441–1445 doi: 10.1093/bioinformatics/btv761 Advance Access Publication Date: 21 January 2016 Discovery Note exception</figDesc><table></table></figure>

			<note place="foot">at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>

			<note place="foot">Proteins of the transglutaminase-like cysteine protease superfamily catalyse various reactions (such as: transglutaminases, proteases, phytochelatin synthases and arylamine N-acetyltransferases) on diverse substrates. Nevertheless, they all contain a conserved catalytic triad (usually Cys-His-Asp/Glu) (Chatterjee et al. 2012; Ginalski et al., 2004; Keillor et al., 2014; Makarova et al., 1999, 2000; Polg ar and Asb oth, 1986; Vivares et al., 2005). These amino acids are conserved as Cys-His-Ser/Thr in human VASH1 and all its homologues at sites that structurally superimpose onto the transglutaminase active centre residues (Fig. 1). This modified catalytic triad (Cys-His-Ser/Thr) thus appears to be essential for the normal function of the vasohibin family. Active sites and catalytic mechanisms of transglutaminase-like cysteine proteases have been extensively studied (Keillor et al., 2014; Polg ar and Asb oth, 1986). In the classical Cys-His-Asn/Asp catalytic triad, the Cys, activated as a thiolate anion by the His residue, plays the major role in the nucleophilic attack the substrate. Both positions, His and Cys, are completely conserved across all members of the vasohibin family (VASH1 residues C169 and H204) (Fig. 1). The third position of the catalytic triad (commonly Asn, Asp or Glu) is known to have a secondary role in catalysis by orienting the His side chain to allow the formation of a thiolate/imidazolium ion pair between Cys and His residues (Vernet et al., 1995). Such a role, we suggest, could also be performed by the hydroxyl groups of the conserved Ser or Thr amino acids (VASH1 residue S221) (Fig. 1). This non-canonical catalytic triad (Cys-His-Ser/Thr) present in the Vasohibin family, is not unique to the transglutaminase-like cysteine protease superfamily, because members of the Transglut_core family (Pfam entry: PF01841) (Punta et al., 2012), part of the transglutaminase-like cysteine protease superfamily, also contain a Cys-His-Thr non-canonical catalytic triad (e.g. A0LIH5_SYNFM from Syntrophobacter fumaroxidans). Another example of a non-canonical catalytic triad is the Cys-His-(O¼C)Trp triad in mSpeB (PDB: 1dki) (Kagawa et al., 2000), where the role of orienting the His residue is taken by the backbone carbonyl group of a Trp amino acid. Despite containing this unconventional catalytic triad, mSpeB is an unusually active protease (Honda-Ogawa et al., 2013). 2.3 Activators, inhibitors and regulators in the Transglutaminase-like cysteine protease superfamily Owing to the higher concentrations of calcium in the extracellular space, diverse secreted proteins possess calcium-dependent activation mechanisms that avoid intracellular activation. Calcium dependent activation is a recurring theme across the transglutaminaselike cysteine protease superfamily (Boyd et al., 2012; Chatterjee et al., 2012; Jang et al., 2014). Calcium-binding sites show a wide range of geometries involving three or four-COOH groups (particularly aspartic and glutamic acids) plus two neutral oxygen donors (usually backbone atoms) (Wang et al., 2009). A calcium-dependent activation mechanism in vasohibin homologues is suggested by the alignment of a conserved amino acid (VASH1-E171) with a known calcium binding residue in LapG protease (LapG-D139) (Fig. 1) (Chatterjee et al., 2012). Experimental evidence will be necessary to confirm these Vasohibin family predicted calcium-binding sites. Angiogenesis is not a new cellular process for members of the transglutaminase-like cysteine protease superfamily. Tissue transglutaminase (also known as transglutaminase 2), for example, and also different members of the cysteine cathepsin family of peptidases, have been frequently implicated in various aspects of vascular morphogenesis (Turk et al., 2012; Wang et al., 2013). The identification of the Vasohibin family as members of the transglutaminase-like cysteine protease superfamily may further clarify the known</note>

			<note place="foot">L.Sanchez-Pulido and C.P.Ponting at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct   xml:id="b0">
	<analytic>
		<title level="a" type="main">SCOP database in 2004: refinements integrate structure and sequence family data</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Andreeva</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="226" to="229" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b1">
	<analytic>
		<title level="a" type="main">Recent advances in the development of tissue transglutaminase (TG2) inhibitors</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Badarau</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Amino Acids</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="119" to="127" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b2">
	<analytic>
		<title level="a" type="main">Tumorigenesis and the angiogenic switch</title>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Bergers</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">L</forename>
				<forename type="middle">E</forename>
				<surname>Benjamin</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Cancer</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="401" to="410" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b3">
	<analytic>
		<title level="a" type="main">Regulation of transglutaminases by nitric oxide</title>
		<author>
			<persName>
				<forename type="first">F</forename>
				<surname>Bernassola</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. N. Y. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">887</biblScope>
			<biblScope unit="page" from="83" to="91" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b4">
	<monogr>
		<title level="m" type="main">LapG, required for modulating biofilm formation by Pseudomonas fluorescens Pf0-1, is a calcium-dependent protease</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<forename type="middle">D</forename>
				<surname>Boyd</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b5">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J. Bacteriol</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="page" from="4406" to="4414" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b6">
	<analytic>
		<title level="a" type="main">Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">K</forename>
				<surname>Chakka</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioorg. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="2221" to="2240" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b7">
	<analytic>
		<title level="a" type="main">Structural characterization of a conserved, calciumdependent periplasmic protease from Legionella pneumophila</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Chatterjee</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Bacteriol</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="page" from="4415" to="4425" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b8">
	<analytic>
		<title level="a" type="main">Inactivation of human arylamine N-acetyltransferase 1 by hydrogen peroxide and peroxynitrite</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">M</forename>
				<surname>Dupret</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Enzymol</title>
		<imprint>
			<biblScope unit="volume">400</biblScope>
			<biblScope unit="page" from="215" to="229" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b9">
	<analytic>
		<title level="a" type="main">Hidden Markov models</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">R</forename>
				<surname>Eddy</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Struct. Biol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="361" to="365" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b10">
	<analytic>
		<title level="a" type="main">Angiogenesis as a therapeutic target</title>
		<author>
			<persName>
				<forename type="first">N</forename>
				<surname>Ferrara</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">S</forename>
				<surname>Kerbel</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">438</biblScope>
			<biblScope unit="page" from="967" to="974" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b11">
	<analytic>
		<title level="a" type="main">HMMER web server: 2015 update</title>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">D</forename>
				<surname>Finn</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="30" to="38" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b12">
	<analytic>
		<title level="a" type="main">BTLCP proteins: a novel family of bacterial transglutaminase-like cysteine proteinases</title>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Ginalski</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Biochem. Sci</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="392" to="395" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b13">
	<analytic>
		<title level="a" type="main">Dali: a network tool for protein structure comparison</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Holm</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Sander</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Biochem. Sci</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="478" to="480" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b14">
	<analytic>
		<title level="a" type="main">Structure of Mesorhizobium loti arylamine N-acetyltransferase 1</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">J</forename>
				<surname>Holton</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="14" to="16" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b15">
	<analytic>
		<title level="a" type="main">Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Honda-Ogawa</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="15854" to="15864" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b16">
	<analytic>
		<title level="a" type="main">Biphasic regulation of angiogenesis by reactive oxygen species</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">S</forename>
				<surname>Huang</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">L</forename>
				<surname>Zheng</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmazie</title>
		<imprint>
			<biblScope unit="page" from="61" to="223" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b17">
	<analytic>
		<title level="a" type="main">Enhanced cancer metastasis in mice deficient in vasohibin-1 gene</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Ito</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">73931</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b18">
	<analytic>
		<title level="a" type="main">Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<forename type="middle">H</forename>
				<surname>Jang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">107005</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b19">
	<analytic>
		<title level="a" type="main">Protein secondary structure prediction based on positionspecific scoring matrices</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<forename type="middle">T</forename>
				<surname>Jones</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="195" to="202" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b20">
	<analytic>
		<title level="a" type="main">Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<forename type="middle">F</forename>
				<surname>Kagawa</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci. USA</title>
		<meeting>. Natl. Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="2000" />
			<biblScope unit="page" from="2235" to="2240" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b21">
	<analytic>
		<title level="a" type="main">Acyl transfer mechanisms of tissue transglutaminase</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">W</forename>
				<surname>Keillor</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioorg. Chem</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="186" to="197" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b22">
	<analytic>
		<title level="a" type="main">Inhibitors of tissue transglutaminase</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">W</forename>
				<surname>Keillor</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Pharmacol. Sci</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="32" to="40" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b23">
	<analytic>
		<title level="a" type="main">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<forename type="middle">D</forename>
				<surname>Kerr</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="page" from="25697" to="25703" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b24">
	<analytic>
		<title level="a" type="main">Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">C</forename>
				<surname>Kim</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatogastroenterology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="251" to="256" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b25">
	<analytic>
		<title level="a" type="main">Distinctive localization and opposed roles of vasohibin1 and vasohibin-2 in the regulation of angiogenesis</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<surname>Kimura</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="4810" to="4818" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b26">
	<analytic>
		<title level="a" type="main">Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Kitahara</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cancer</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">99</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b27">
	<analytic>
		<title level="a" type="main">Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<surname>Koyanagi</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol. Lett</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1058" to="1062" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b28">
	<analytic>
		<title level="a" type="main">Structural and biochemical characterization of an active arylamine N-acetyltransferase possessing a non-canonical Cys-His-Glu catalytic triad</title>
		<author>
			<persName>
				<forename type="first">X</forename>
				<surname>Kubiak</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="22493" to="22505" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b29">
	<analytic>
		<title level="a" type="main">Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Kukongviriyapan</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Xenobiotica</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="15" to="28" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b30">
	<analytic>
		<title level="a" type="main">A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases</title>
		<author>
			<persName>
				<forename type="first">K</forename>
				<forename type="middle">S</forename>
				<surname>Makarova</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Protein Sci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1714" to="1719" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b31">
	<analytic>
		<title level="a" type="main">A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae</title>
		<author>
			<persName>
				<forename type="first">K</forename>
				<forename type="middle">S</forename>
				<surname>Makarova</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Biochem. Sci</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="50" to="52" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b32">
	<analytic>
		<title level="a" type="main">T-Coffee: a novel method for fast and accurate multiple sequence alignment</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Notredame</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="page" from="205" to="217" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b33">
	<analytic>
		<title level="a" type="main">Cellular functions of tissue transglutaminase</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<forename type="middle">V</forename>
				<surname>Nurminskaya</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Belkin</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. Rev. Cell Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="page" from="1" to="97" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b34">
	<analytic>
		<title level="a" type="main">Structure-function of falcipains: malarial cysteine proteases</title>
		<author>
			<persName>
				<forename type="first">K</forename>
				<forename type="middle">C</forename>
				<surname>Pandey</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Dixit</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Trop. Med</title>
		<imprint>
			<biblScope unit="page">345195</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b35">
	<analytic>
		<title level="a" type="main">The basic difference in catalyses by serine and cysteine proteinases resides in charge stabilization in the transition state</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Polg Ar</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Asb Oth</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Theor. Biol</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="323" to="326" />
			<date type="published" when="1986" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b36">
	<analytic>
		<title level="a" type="main">The Pfam protein families database</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Punta</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="290" to="301" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b37">
	<analytic>
		<title level="a" type="main">MEROPS: the database of proteolytic enzymes, their substrates and inhibitors</title>
		<author>
			<persName>
				<forename type="first">N</forename>
				<forename type="middle">D</forename>
				<surname>Rawlings</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="503" to="509" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b38">
	<analytic>
		<title level="a" type="main">Comparative protein modelling by satisfaction of spatial restraints</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Sali</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">T</forename>
				<forename type="middle">L</forename>
				<surname>Blundell</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">234</biblScope>
			<biblScope unit="page" from="779" to="815" />
			<date type="published" when="1993" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b39">
	<analytic>
		<title level="a" type="main">The vasohibin family: a novel family for angiogenesis regulation</title>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Sato</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biochem</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="5" to="11" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b40">
	<analytic>
		<title level="a" type="main">Novel Link between Inhibition of Angiogenesis and Tolerance to Vascular Stress</title>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Sato</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Atheroscler. Thromb</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="327" to="334" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b41">
	<analytic>
		<title level="a" type="main">The HHpred interactive server for protein homology detection and structure prediction</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Sö Ding</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="244" to="248" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b42">
	<analytic>
		<title level="a" type="main">Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<surname>Shibuya</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1051" to="1057" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b43">
	<analytic>
		<title level="a" type="main">Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Sim</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="2705" to="2725" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b44">
	<analytic>
		<title level="a" type="main">Automatic annotation of eukaryotic genes, pseudogenes and promoters</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Solovyev</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b45">
	<analytic>
		<title level="a" type="main">Scoredist: a simple and robust protein sequence distance estimator</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<forename type="middle">L</forename>
				<surname>Sonnhammer</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Hollich</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">108</biblScope>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b46">
	<analytic>
		<title level="a" type="main">Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion</title>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Suzuki</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="3094" to="3101" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b47">
	<analytic>
		<title level="a" type="main">Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis</title>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Takahashi</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cancer Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1135" to="1146" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b48">
	<analytic>
		<title level="a" type="main">Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Tu</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Med. Rep</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="663" to="669" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b49">
	<analytic>
		<title level="a" type="main">Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Turk</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="141" to="150" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b50">
	<analytic>
		<title level="a" type="main">Cysteine cathepsins: from structure, function and regulation to new frontiers</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Turk</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1824</biblScope>
			<biblScope unit="page" from="68" to="88" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b51">
	<analytic>
		<title level="a" type="main">VEGF signaling through NADPH oxidase-derived ROS</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Ushio-Fukai</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antioxid. Redox Signal</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="731" to="739" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b52">
	<analytic>
		<title level="a" type="main">Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Ushio-Fukai</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">N</forename>
				<surname>Urao</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antioxid. Redox Signal</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2517" to="2533" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b53">
	<analytic>
		<title level="a" type="main">Structural and functional roles of asparagine 175 in the cysteine protease papain</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<surname>Vernet</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="16645" to="16652" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b54">
	<analytic>
		<title level="a" type="main">A papain-like enzyme at work: native and acyl-enzyme intermediate structures in phytochelatin synthesis</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Vivares</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci. USA</title>
		<meeting>. Natl. Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="2005" />
			<biblScope unit="page" from="18848" to="18853" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b55">
	<analytic>
		<title level="a" type="main">Towards predicting Ca2þ-binding sites with different coordination numbers in proteins with atomic resolution</title>
		<author>
			<persName>
				<forename type="first">X</forename>
				<surname>Wang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proteins</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="787" to="798" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b56">
	<analytic>
		<title level="a" type="main">A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis</title>
		<author>
			<persName>
				<forename type="first">Z</forename>
				<surname>Wang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">808</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b57">
	<analytic>
		<title level="a" type="main">Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis</title>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Watanabe</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="898" to="907" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b58">
	<analytic>
		<title level="a" type="main">The Universal Protein Resource (UniProt): an expanding universe of protein information</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<forename type="middle">H</forename>
				<surname>Wu</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="187" to="191" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b59">
	<analytic>
		<title level="a" type="main">Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Xian</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="20467" to="20473" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b60">
	<analytic>
		<title level="a" type="main">Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma</title>
		<author>
			<persName>
				<forename type="first">X</forename>
				<surname>Xue</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1724" to="1734" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b61">
	<analytic>
		<title level="a" type="main">Arylamine N-acetyltransferases: a structural perspective</title>
		<author>
			<persName>
				<forename type="first">X</forename>
				<surname>Zhou</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="748" to="760" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b62">
	<monogr>
		<title level="m" type="main">Vasohibins: new transglutaminase-like cysteine proteases</title>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>